HR001124S0032_Attachment_A_Abstract_Summary_Slide_Template.pptx

This document is an Abstract Summary Slide Template for the Broad-Spectrum Antagonists For Editors (B-SAFE) federal grant opportunity, Solicitation Number HR001124S0032, from the Defense Advanced Research Projects Agency (DARPA).

The B-SAFE program seeks transformative approaches to discover or design novel inhibitors of gene editing technologies, with a focus on enhancing the activity, utility, and breadth of coverage of these inhibitors. DARPA is interested in identifying inhibitor molecules for gene editing technologies beyond CRISPR-Cas systems, to promote the safe and controlled use of these technologies. The program aims to scale up top-performing inhibitor molecules for testing and evaluation by Department of Defense stakeholders. This grant opportunity falls under DARPA's Research and Technology Development program (CFDA 12.910).